Leigh syndrome: Clinical features and biochemical and DNA abnormalities

Annals of Neurology - Tập 39 Số 3 - Trang 343-351 - 1996
S. Rahman1, Rozanne B. Blok2, H H Dahl2, D. M. Danks2, Denise M. Kirby2, C.W. Chow3, John Christodoulou4, David R. Thorburn2
1Murdoch Institute, Royal Children's Hospital, Parkville, Victoria, Australia
2The Murdoch Institute for Research into Birth Defects, Royal Children Hospital, Melbourne, Australia
3Department of Anatomical Pathology, Royal Children's Hospital, Melbourne, Australia
4Department of Paediatrics and Child Health, Children's Hospital, Sydney, Australia

Tóm tắt

AbstractWe investigated the etiology of Leigh syndrome in 67 Australian cases from 56 pedigrees, 35 with a firm diagnosis and 32 with some atypical features. Biochemical or DNA defects were determined in both groups, ie, 80% in the tightly defined group and 41% in the “Leigh‐like” group. Eleven patients had mitochondrial DNA point mutations (nucleotide [nt] 8993 T to G, nt 8993 T to C, or nt 8344 A to G) and 1 Leigh‐like patient had a heteroplasmic deletion. Twenty‐nine patients had enzyme defects, ie, 13 respiratory chain complex I, 9 complex IV, and 7 pyruvate dehydrogenase complex (PDHC). Complex I deficiency is more common than recognized previously. Six PDHC‐deficient patients had mutations in the X‐chromosomal gene encoding the Elα subunit of PDHC. Parental consanguinity suggested autosomal recessive inheritance in two complex IV‐deficient sibships. We found no strong correlation between the clinical features and basic defects. An assumption of autosomal recessive inheritance (frequently made in the past) would have been wrong in nearly one‐half (1 1 of 28 tightly defined and 18 of 41 total patients) of those in whom a cause was found. A specific defect must be identified if reliable genetic counseling is to be provided.

Từ khóa


Tài liệu tham khảo

10.1136/jnnp.14.3.216

10.1111/j.1469-8749.1972.tb02563.x

10.1016/S0303-8467(87)80020-3

DeVivo DC, 1991, Modern perspectives of child neurology, 27

10.1007/BF00295603

10.1016/0888-7543(89)90297-8

Tatuch Y, 1992, Heteroplasmic mtDNA mutation (T‐G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high, Am J Hum Genet, 50, 852

10.1212/WNL.42.11.2168

10.1002/ana.410320428

10.1016/S0022-3476(05)83431-6

10.1177/088307389300800204

10.1002/ana.410340612

10.1002/ana.410340319

10.1212/WNL.44.5.972

10.1016/0140-6736(91)92981-7

10.1016/0140-6736(91)91090-H

10.1212/WNL.43.6.1200

Shoffner JM, 1995, The metabolic and molecular bases of inherited disease, 1535

Holt IJ, 1990, A new mitochondrial disease associated with mitochondrial DNA het‐ eroplasmy, Am J Hum Genet, 46, 428

10.1016/0092-8674(90)90059-N

10.1038/348651a0

10.1111/j.1440-1754.1993.tb00536.x

Blok RB, 1995, A to‐poisomerase II cleavage site is associated with a novel mitochondrial DNA deletion, Hum Genet, 35, 75

10.1006/bmme.1995.1052

10.1016/0888-7543(90)90275-Y

10.1038/290457a0

Zeviani M, 1991, Rapid detection of the A‐tG(8344) mutation of mtDNA in Italian families with myoclonus epilepsy and ragged‐red fibers (MERRF), Am J Hum Genet, 48, 203

10.1016/0005-2728(90)90118-N

10.1016/0022-510X(91)90088-O

10.1016/0009-8981(94)90055-8

10.1016/0003-2697(92)90453-E

10.1016/S0006-291X(05)80769-7

10.1016/S0021-9258(19)52451-6

10.1006/bmmb.1994.1004

10.1016/S0006-291X(05)81016-2

10.1002/9780470110188.ch13

10.1016/0076-6879(69)13005-0

10.1042/bj2390089

10.1203/00006450-197901000-00009

10.1177/088307389000500214

10.1016/S0022-3476(79)80286-3

10.1016/0888-7543(91)90342-C

Takakubo F, 1995, An amino acid substitution in the pyruvate dehydrogenase El a gene affecting mitochondrial import of the precursor protein, Am J Hum Genet, 57, 772

10.1093/hmg/2.4.449

10.1002/humu.1380030210

10.1212/WNL.39.5.697

Juvonen V, 1993, Reevaluation of the linkage of an optic atrophy susceptibility gene to X‐chromosomal markers in Finnish families with Leber hereditary optic neuro‐ retinopathy (LHON), Am J Hum Genet, 53, 289

10.1016/0140-6736(93)91105-U

Merante F, 1993, A biochemically distinct form of cytochrome oxidase (COX) deficiency in the Saguenay‐Lac‐Saint‐Jean region of Quebec, Am J Hum Genet, 53, 481

10.1007/BF01799214